Sponsor:
Rush University Medical Center
Code:
NCT07487246
Conditions
Pain Management
Abortion
Second Trimester Abortion
Dilation and Evacuation
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Ketorolac
oral ibuprofen
Placebo
Lidocaine HCl 1%
Saline
Brief summary:
Conditions
Pain Management
Abortion
Second Trimester Abortion
Dilation and Evacuation
Study ID
NCT07487246
Start date
Jun 29, 2026
Status verified date
Jul, 2026
Completion date
Apr 30, 2027
Anticipated
Primary completion date
Apr 30, 2027
Anticipated
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
76 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: Intervention Treatment Group
active comparator: Standard Treatment
Interventions
Ketorolac
oral ibuprofen
Placebo
Lidocaine HCl 1%
Saline
Primary outcome measure
Central contacts
Locations
Rush University Medical Center
Recruiting
Chicago, Illinois, United States, 60612
Sponsor
Rush University Medical Center
Last update posted
Jul 6, 2026
Last verified
Jul, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Rush University Medical Center on 2026-07-06.